Manja Boerman - 24 Aug 2022 Form 3 Insider Report for Catalent, Inc.

Role
Pres. BioModalities Division
Signature
/s/ Jose Ibietatorremendia, attorney-in-fact
Issuer symbol
N/A
Transactions as of
24 Aug 2022
Net transactions value
$0
Form type
3
Filing time
26 Aug 2022, 18:11:48 UTC
Next filing
07 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTLT Common Stock 13,260 24 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTLT Options to purchase Common Stock 24 Aug 2022 Common Stock 8,445 $51.43 Direct F2
holding CTLT Options to purchase Common Stock 24 Aug 2022 Common Stock 6,158 $88.10 Direct F3
holding CTLT Options to purchase Common Stock 24 Aug 2022 Common Stock 4,579 $113.00 Direct F4
holding CTLT Options to purchase Common Stock 24 Aug 2022 Common Stock 5,251 $107.63 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The options vest and become exercisable in four equal annual installments beginning on December 2, 2020.
F3 The options vest and become exercisable in four equal annual installments beginning on July 30, 2021.
F4 The options vest and become exercisable in four equal annual installments beginning on July 26, 2022.
F5 The options vest and become exercisable in four equal annual installments beginning on July 26, 2023.

Remarks:

EXHIBIT LIST: EX-24 Boerman PoA (10Jul2022)